![Banmeet Anand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Banmeet Anand is currently the Senior Vice President-Translational Medicine at Harpoon Therapeutics, Inc. Prior to this, he worked as the Vice President & Head-Nonclinical Development at Molecular Templates, Inc. He holds a doctorate degree from the University of Missouri.
| Sociétés | Poste | Début |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 06/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
